Rab27b: A Modulator of Lysosomal Function and Alpha-Synuclein Clearance in Parkinson's Disease
Open Access
- 22 April 2026
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 46 (16)
Abstract
No abstract availableKeywords
Funding Information
- Cure Sanfilippo Foundation
- National MPS Society
This publication has 10 references indexed in Scilit:
- Emerging roles of Rab27 proteins: from normal to cancer stem cellsBiochemical and Biophysical Research Communications, 2025
- Rab27b Promotes Lysosomal Function and Alpha-Synuclein Clearance in NeuronsJournal of Neuroscience, 2025
- Novel strategies targeting mitochondria-lysosome contact sites for the treatment of neurological diseasesFrontiers in Molecular Neuroscience, 2025
- Mechanisms of autophagy–lysosome dysfunction in neurodegenerative diseasesNature Reviews Molecular Cell Biology, 2024
- The autophagy–lysosome pathway: a potential target in the chemical and gene therapeutic strategies for Parkinson’s diseaseNeural Regeneration Research, 2024
- Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy modelsAutophagy, 2022
- A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transferJournal of Clinical Investigation, 2020
- The GTPase Rab27b regulates the release, autophagic clearance, and toxicity of α-synucleinJournal of Biological Chemistry, 2020
- Glucocerebrosidase and its relevance to Parkinson diseaseMolecular Neurodegeneration, 2019
- The lysosomal storage disease continuum with ageing-related neurodegenerative diseaseAgeing Research Reviews, 2016